Written question asked by Lord Beamish (Labour) on Monday, 28 November 2022, in the House of Commons. It was due for an answer on Wednesday, 30 November 2022. It was answered by George Freeman (Conservative) on Tuesday, 6 December 2022 on behalf of the Department for Business, Energy and Industrial Strategy.
Life Sciences: Innovation
- Question
-
To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential of (a) artificial intelligence, (b) organ-on-a-chip technology and (c) other New Approach Methodologies to benefit the UK economy: and whether he considers the development of these technologies to be a particular area of strength for the UK.
- Answer
-
Harnessing the potential of AI is predicted to grow the economy by £232bn or 10.3% of GDP by 2030. In 2021 the Government published its National AI Strategy – a 10 year plan to ensure the UK remains a leader in AI. We are behind only the US and China and home to a third of Europe’s AI companies – more than 1,300 with a turnover of $2B.
Through UK Research and Innovation, the National Centre for reduction, replacement and refinement of animal testing in medicine has committed £100 million in research to develop new approach methodologies, including organ-on-a-chip.
Secondary information
- Type
- Written question
- Reference
- 97474
- Session
- 2022-23
- Subjects
- Innovation Organs Artificial intelligence Microprocessors
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-12-06 17:59:57 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/97474
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/97474
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/97474